University of Nevada

Amber Howerton

Ernesto Abel-Santos

A method of treating a patient to reduce risk of developing Clostridium difficile-associated disease or reducing existing Clostridium difficile-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.

Reducing risk of contracting clostridium-difficile associated disease

A method of treating a patient to reduce risk of developing-associated disease or reducing existing-associated disease in a mammalian subject involves administering to a mammalian subject an effective amount of a germination-inhibiting compound derived from taurocholate. Novel compounds of this class are also provided.

Growing community of inventors

Las Vegas, NV, United States of America

Amber Howerton